insert an image 968px x 220px


Board Changes at Gentronix Ltd.

Posted on November 23, 2016 by Chris Hughes

The Genotoxicity specialist Gentronix is pleased to announce that Dr. Matt Tate has joined the Gentronix Ltd Board as Technical Director, effective 1st November 2016.  Dr Tate joined the company in 2006 and has developed an in-depth knowledge of the field with several publications to his name and an ability to provide quality, customised advice to customers. John Nicholson, Gentronix Chairman, commented that “Matt Tate has developed a terrific awareness of what is current in the genotoxicity field and has become increasingly well regarded in his field and we are confident that he will make a significant contribution to the Gentronix…

Read the rest of this news item

New European Sales Manager

Posted on July 19, 2016 by Chris Hughes


As Gentronix continues to expand its workforce and services we are delighted to announce the appointment of Dr Fabio Spreafico as our European Sales Manager.  Joining us from his previous role as Business Development Manager at BASF subsidiary, Metanomics Health GmbH in Berlin, Fabio brings over 20 years of scientific and business experience to the company. In his new role he will be based primarily near Milan, and will work to bring Gentronix and our offerings to new and existing customers in the European market. Enquires and contact details for Gentronix can be found at

Read the rest of this news item

Gentronix is recruiting

Posted on March 1, 2016 by Chris Hughes

Gentronix is expanding and currently looking to recruit study investigators for the Ames and Micronucleus assays.  Further details are available on our careers page. Recruitment for these positions has now expired.

Read the rest of this news item

Gentronix announces multi-year agreement for provision of GreenScreen HC technology to major Chinese research institute, Shanghai Institute of Materia Medica.

Posted on March 18, 2015 by stevebeasley

(Alderley Edge, Cheshire, UK – 18.03.2015) UK based Gentronix Limited, the specialist genetic toxicology company, today announced it has signed a three year technology access deal with one of China’s most prestigious research intensive institutes, Shanghai Institute Materia Medica (SIMM), Chinese Academy of Sciences (CAS). Under the terms of the multi-year agreement, Gentronix will provide training & installation support and on-going reagent supply to SIMM scientists to enable use of its proprietary technology, GreenScreen HC, for the detection of chemicals that may cause DNA damage. The human cell based technology will be used to further expand the ongoing SIMM –…

Read the rest of this news item